Spark Newswire Spark Newswire
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
News by Category
  • After-Hours Center
  • Analyst Color
  • Analyst Ratings
  • Asia
  • Asset Sales
  • Binary Options
  • Biotech
  • Bonds
  • Broad U.S. Equity ETFs
  • Buybacks
  • Cannabis
  • Commodities
  • Contracts
  • Crowdsourcing
  • Cryptocurrency
  • Currency ETFs
  • Dividends
  • Downgrades
  • Earnings
  • Earnings Beats
  • Earnings Misses
  • Econ #s
  • Economics
  • Education
  • Emerging Market ETFs
  • Emerging Markets
  • Entertainment
  • Entrepreneurship
  • ESG
  • ETFs
  • Eurozone
  • Events
  • Exclusives
  • FDA
  • Federal Reserve
  • Financial Advisors
  • Financing
  • Fintech
  • Forex
  • Futures
  • Gaming
  • General
  • Global
  • Government
  • Guidance
  • Health Care
  • Hedge Funds
  • Hot
  • Initiation
  • Insider Trades
  • Insurance
  • Interview
  • Intraday Update
  • IPOs
  • Large Cap
  • Latin America
  • Legal
  • Long Ideas
  • M&A
  • Macro Economic Events
  • Management
  • Market-Moving Exclusives
  • Markets
  • Media
  • Mid Cap
  • Movers
  • Movers & Shakers
  • Mutual Funds
  • New ETFs
  • News
  • Offerings
  • Opinion
  • Options
  • Penny Stocks
  • Personal Finance
  • Politics
  • Pre-Market Outlook
  • Press Releases
  • Previews
  • Price Target
  • Psychedelics
  • Psychology
  • Real Estate
  • Regulations
  • REIT
  • Reiteration
  • Restaurants
  • Retail Sales
  • Reviews
  • Rumors
  • SEC
  • Sector ETFs
  • Short Ideas
  • Short Sellers
  • Signals
  • Small Business
  • Small Cap
  • Small Cap Analysis
  • Small-Cap
  • Social Media
  • SPACE
  • Specialty ETFs
  • Sports
  • Sports Betting
  • Startups
  • Stock Split
  • Success Stories
  • Tech
  • Technicals
  • Termination
  • Top Stories
  • Topics
  • Trading Ideas
  • Travel
  • Treasuries
  • Uncategorized
  • Upgrades
Spark Newswire Spark Newswire
Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
Spark Newswire Spark Newswire
Filter By Ticker
Search By Date To
Today | Yesterday | This week

Latest news

Group By Ticker
Sort By
Newest | Oldest
Read More
1 minute read
  • FDA
  • Movers
  • News
  • Trading Ideas

Why BriaCell Therapeutics Stock Is Surging Today

By Adam Eckert
Today, 3:29 PM
BriaCell Therapeutics Corp (NASDAQ: BCTX) shares are trading higher Wednesday after the company announced the U.S. Food and Drug Administration granted Fast Track status to Bria-IMT for the treatment of metastatic breast cancer.

BCTX

Read More
2 minute read
  • Biotech
  • FDA
  • General
  • News

BriaCell Reports Received FDA Fast Track Approval For Its Targeted Breast Cancer Immunotherapy

By Benzinga Newsdesk
Today, 3:29 PM
U.S. Food and Drug Administration (FDA) has granted Fast Track status to BriaCell’s lead candidate, Bria-IMT™, for the treatment of metastatic breast cancer. Fast Track improves the speed and frequency

BCTX

Read More
10 minute read
  • Uncategorized

BCTX: Second Quarter Results

By Zacks Small Cap Research
Today, 3:29 PM
By John Vandermosten, CFA NASDAQ:BCTX READ THE FULL BCTX RESEARCH REPORT

APVO

Read More
1 minute read
  • Biotech
  • General

BriaCell Adds Two Clinical Trial Sites

By Bill Haddad
Today, 3:29 PM
BriaCell Therapeutics Corp. (NASDAQ:BCTX, BCTXW)) (TSX:BCT) (“BriaCell” or the “Company”), a clinical-stage biotechnology company specializing in targeted immunotherapies for advanced breast

BCTX

Read More
1 minute read
  • Analyst Ratings
  • Initiation
  • News
  • Price Target

HC Wainwright & Co. Initiates Coverage On BriaCell Therapeutics with Buy Rating, Announces Price Target of $25

By Benzinga Newsdesk
Today, 3:29 PM
HC Wainwright & Co. analyst Emily Bodnar initiates coverage on BriaCell Therapeutics (NASDAQ:BCTX) with a Buy rating and announces Price Target of $25.

BCTX

Read More
5 minute read
  • Markets
  • Movers
  • News
  • Penny Stocks
  • Pre-Market Outlook
  • Small Cap
  • Trading Ideas

65 Biggest Movers From Yesterday

By Lisa Levin
Today, 3:29 PM
Gainers Exterran Corporation (NYSE: EXTN) shares surged 59.7% to close at $4.79 on Monday after the company said it would merge with Enerflex to create a premier integrated global provider of energy infrastructure.

AIH

Read More
4 minute read
  • Intraday Update
  • Markets
  • Movers
  • News
  • Penny Stocks
  • Small Cap
  • Trading Ideas

54 Stocks Moving In Monday’s Mid-Day Session

By Lisa Levin
Today, 3:29 PM
Gainers Exterran Corporation (NYSE: EXTN) shares jumped 52.4% to $4.5720 after the company said it would merge with Enerflex to create a premier integrated global provider of energy infrastructure.

AMST

Read More
4 minute read
  • Uncategorized

BCTX: Game, Set and Match: HLAs Score Success

By Zacks Small Cap Research
Today, 3:29 PM
By John Vandermosten, CFA NASDAQ:BCTX READ THE FULL BCTX RESEARCH REPORT

BCTX

Read More
2 minute read
  • Insider Trades
  • News

BriaCell Highlights Certain Members Of Co. Board, Mgmt. Team Have Indicated Intent To Use Personal Funds To Buy ~10% Of Common Stock, Or ~1.59M Shares

By Benzinga Newsdesk
Today, 3:29 PM
Insiders intend to acquire up to approximately 10% of BriaCell’s basic common shares, or 1.59 million shares Corporate buyback program will continue; 501,703 shares and 143,236 warrants repurchased since

BCTX

Read More
4 minute read
  • Intraday Update
  • Markets
  • Movers
  • News
  • Penny Stocks
  • Small Cap
  • Trading Ideas

50 Stocks Moving In Wednesday’s Mid-Day Session

By Lisa Levin
Today, 3:29 PM
Gainers

ABUS

Posts navigation

Previous 1 2 3 … 5 Next
Free Newsletter subscribe

Stock Market Ideas & Analysis

Stay up-to-date with the same information professionals use.
Spark Newswire Spark Newswire
  • Newswire
  • Registration
  • Log In
  • Settings
  • Privacy Policy
  • Terms of Service
© 2021 Spark Newswire
All Rights Reserved.

All news is property of their respective owners. Terms of Service